ClinicalTrials.gg
RecruitingNCT07520916MPE-RPUpdated Apr 9, 2026

The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatectomy

An interventional study of Mobile-Based Perioperative Education Program and Standard Perioperative Care in Prostate Cancer (Post Prostatectomy), Urinary Incontinence (UI) and Erectile Dysfunction Following Radical Prostatectomy, sponsored by Giresun University. Recruiting at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by Giresun University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 111 studies in Prostatic Neoplasms with a site in Turkey — 22 open to participants now, 42 under way, 21 of them phase 3. Prostatic Neoplasms · Turkey.

Planned enrollment
62nd of 90
78 · median 226
Started
2026
with 12 others
No phase
40 of 111
6 open now
Primary completion
2027-04
later than 24 of 41 live
Registered
101st of 111
by date

Among the 111 studies in Prostatic Neoplasms with a site in Turkey, this one is the 62nd largest by planned enrollment of the 90 interventional ones that give a count, is one of 13 that started in 2026, is one of 40 with no phase, reaches primary completion later than 24 of the 41 other live ones, and was the 101st registered.

Prostatic Neoplasms

7,058 studies on the registry are indexed under Prostatic Neoplasms; 1,582 are open to participants now.

Browse Prostatic Neoplasms studies →

Open to participants now

22 of the 111 studies in Prostatic Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,236 Prostatic Neoplasms studies recruiting now, 933 (75%) set no upper age limit and 77 (6%) stop at 75 or younger; 67 take children under 18; 82 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 111 studies in Prostatic Neoplasms with a site in Turkey, or all of them as a file.
02

Study summary

This prospective randomized controlled study aims to evaluate the effect of mobile-based perioperative education on postoperative urinary incontinence and erectile function in patients undergoing radical prostatectomy. Patients scheduled for radical prostatectomy will be assigned to either an intervention group or a control group. The intervention group will receive standard care plus a structured mobile application-based perioperative education program including video-assisted pelvic floor muscle training, perioperative education modules, reminders, and follow-up components. The control group will receive routine perioperative care and standard patient education. Data will be collected preoperatively, after urinary catheter removal, and at 1 month and 3 months after surgery. The primary outcomes are urinary incontinence and erectile function, assessed using the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), the International Index of Erectile Function-5 (IIEF-5), and a 24-hour pad assessment. Secondary outcomes include lower urinary tract symptoms and disease-specific quality of life assessed by the International Prostate Symptom Score (IPSS), psychological status assessed by the Depression Anxiety Stress Scale-21 (DASS-21), and system usability assessed by the Turkish version of the Computer System Usability Questionnaire-Short Version (T-CSUQ-SV)

Read the detailed description

Prostate cancer is one of the most common malignancies in men, and radical prostatectomy is a major curative treatment option for localized disease. However, urinary incontinence and erectile dysfunction remain among the most important postoperative complications affecting patients' functional recovery and quality of life. Access to structured perioperative education and rehabilitation may be limited because of time, cost, travel burden, and restricted access to specialized support. Mobile health-based interventions may provide an accessible and scalable approach for delivering perioperative education, exercise guidance, reminders, and follow-up support.

This study is designed to evaluate the effectiveness of a mobile-based perioperative education program for patients undergoing radical prostatectomy. Participants will be assigned to either an intervention group or a control group. The intervention group will receive routine perioperative care in addition to a structured mobile application-based program that includes video-assisted pelvic floor muscle training, perioperative education content, reminder notifications, and follow-up support. The control group will receive routine perioperative care and standard patient education.

Data will be collected at four time points: before surgery, after urinary catheter removal, at 1 month after surgery, and at 3 months after surgery. The primary outcomes of the study are postoperative urinary incontinence and erectile function. Urinary incontinence will be assessed using the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and a 24-hour pad assessment. Erectile function will be evaluated using the International Index of Erectile Function-5 (IIEF-5). Secondary outcomes will include lower urinary tract symptoms and disease-specific quality of life assessed by the International Prostate Symptom Score (IPSS), psychological status assessed by the Depression Anxiety Stress Scale-21 (DASS-21), and usability of the mobile application assessed by the Turkish version of the Computer System Usability Questionnaire-Short Version (T-CSUQ-SV).

The findings of this study are expected to contribute to the development of accessible and structured perioperative care models for patients undergoing radical prostatectomy and to provide evidence on the effectiveness of mobile-based perioperative education in improving postoperative functional outcomes.

03

Conditions studied

  • Prostate Cancer (Post Prostatectomy)
  • Urinary Incontinence (UI)
  • Erectile Dysfunction Following Radical Prostatectomy

Keywords

  • Radical Prostatectomy
  • Mobile Health
  • mHealth
  • Perioperative Education
  • Pelvic Floor Muscle Training
  • Urinary Incontinence
  • Erectile Function
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with prostate cancer and scheduled for elective radical prostatectomy (open, laparoscopic, or robotic)
  • Aged 18 years or older
  • Planned to undergo surgery at the study center(s)
  • Able to use a smartphone and having sufficient digital literacy to operate the mobile application
  • Provided written after being informed about the study

Exclusion criteria

Exclusion Criteria:

  • Pre-existing urinary incontinence or erectile dysfunction before surgery
  • Severe cognitive impairment or severe visual or hearing impairment
  • Previous pelvic radiotherapy or a history of major pelvic surgery
  • Presence of severe comorbidity or terminal illness that may interfere with adherence to the study protocol
  • Technological insufficiency preventing the use of the mobile application
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
78 participants (estimated)

Study arms

  • Experimental
    Mobile-Based Perioperative Education

    Participants will receive routine perioperative care in addition to a structured mobile application-based perioperative education program including video-assisted pelvic floor muscle training, perioperative education content, reminders, and follow-up support.

    Behavioral: Mobile-Based Perioperative Education Program

  • Active comparator
    Standard Perioperative Care

    Participants will receive routine perioperative care and standard patient education.

    Other: Standard Perioperative Care

Interventions

  • BehavioralMobile-Based Perioperative Education Program

    A structured mobile application-based perioperative education program including video-assisted pelvic floor muscle training, perioperative education content, reminder notifications, and follow-up support.

  • OtherStandard Perioperative Care

    Routine perioperative care and standard patient education provided according to institutional practice.

06

What researchers measure

Primary outcomes

  1. Urinary Incontinence Severity

    Urinary incontinence severity will be assessed using the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Higher scores indicate greater symptom severity and greater impact on quality of life.

    Time frame: Before surgery, after urinary catheter removal, at 1 month after surgery, and at 3 months after surgery

  2. Erectile Function

    Erectile function will be assessed using the International Index of Erectile Function-5 (IIEF-5). Higher scores indicate better erectile function.

    Time frame: Before surgery, after urinary catheter removal, at 1 month after surgery, and at 3 months after surgery

  3. Urinary Leakage Severity by 24-Hour Pad Use

    Urinary leakage severity will be evaluated according to 24-hour pad use. Daily use of 1 to 2 pads will be classified as mild, 3 to 5 pads as moderate, and more than 5 pads as severe urinary incontinence.

    Time frame: After urinary catheter removal, at 1 month after surgery, and at 3 months after surgery

Secondary outcomes

  1. Lower Urinary Tract Symptoms and Disease-Specific Quality of Life

    Assessed using the International Prostate Symptom Score (IPSS), including symptom severity and the disease-specific quality of life item.

    Time frame: Before surgery, after urinary catheter removal, at 1 month after surgery, and at 3 months after surgery

  2. Psychological Status

    Assessed using the Depression Anxiety Stress Scale-21 (DASS-21).

    Time frame: Before surgery, after urinary catheter removal, at 1 month after surgery, and at 3 months after surgery

  3. System Usability

    Usability of the mobile application will be assessed using the Turkish version of the Computer System Usability Questionnaire-Short Version (T-CSUQ-SV) to evaluate participants' ability to use the mobile application.

    Time frame: Before surgery

07

Study locations

1 of 1 sites recruiting
  • Giresun Prof. Dr. A. İlhan Özdemir State Hospital
    Giresun, Giresun 28000, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — No plan has been established to share individual participant data with other researchers.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Apr 2027, 12 months after the start.

Of 1,104 non-industry interventional studies with no phase under Prostatic Neoplasms, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 87. This study's planned 12 months is below that.

Counting every sponsor, half of 1,162 studies reached it within 43 months; a quarter within 22 and three quarters within 86.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2026
First posted
Apr 9, 2026
StartActual
Apr 2, 2026
Primary completionEst.
Apr 2, 2027
CompletionEst.
Apr 2, 2027
Last update
Apr 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07520916
Lead sponsor
Giresun University
Responsible party
Alkay Kara (Assistant Professor, PhD, Giresun University) — Principal investigator
First posted
Apr 9, 2026
Start date
Apr 2, 2026
Primary completion
Apr 2, 2027 (estimated)
Completion
Apr 2, 2027 (estimated)
Last update
Apr 9, 2026

Study contacts

ALKAY KARA, PhD
Contact
alkay@outlook.com.tr
+905394416497

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion